RadNet, Inc. Financing Cash Flow
RadNet, Inc. (RDNT) reported Financing Cash Flow of $222.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-10
- RadNet, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $240.22M, a 159.90% increase year-over-year.
- RadNet, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$17.50M.
- RadNet, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$7.39M.
- RadNet, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$5.32M.
- RadNet, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $72.21M, a 81.86% decline from fiscal 2024.
- RadNet, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $397.95M, a 103.41% increase from fiscal 2023.
- RadNet, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $195.63M, a 108.91% increase from fiscal 2022.
- RadNet, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $93.65M, a 10.53% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $240.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $222.72M 10-Q · filed 2026-08-10 | $215.32M derived: sum of 3 quarters · filed 2026-08-10 | $210.00M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | -$17.50M 10-Q · filed 2026-05-11 | -$24.90M derived: sum of 2 quarters · filed 2026-05-11 | -$30.21M derived: sum of 3 quarters · filed 2026-05-11 | $62.21M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | -$7.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$12.71M derived: sum of 2 quarters · filed 2026-03-02 | $79.72M derived: sum of 3 quarters · filed 2026-08-10 | $72.21M 10-K · filed 2026-03-02 | |||
| 2025-09-30 | -$5.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $87.11M derived: sum of 2 quarters · filed 2026-08-10 | $79.60M 10-Q · filed 2025-11-10 | $77.48M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-06-30 | $92.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $84.92M 10-Q · filed 2026-08-10 | $82.80M derived: sum of 3 quarters · filed 2026-08-10 | $78.46M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | -$7.51M 10-Q · filed 2026-05-11 | -$9.63M derived: sum of 2 quarters · filed 2026-05-11 | -$13.96M derived: sum of 3 quarters · filed 2026-05-11 | $162.14M derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | -$2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$6.45M derived: sum of 2 quarters · filed 2026-03-02 | $169.65M derived: sum of 3 quarters · filed 2026-03-02 | $397.95M 10-K · filed 2026-03-02 | |||
| 2024-09-30 | -$4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $171.77M derived: sum of 2 quarters · filed 2025-11-10 | $400.07M 10-Q · filed 2025-11-10 | $364.60M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-06-30 | $176.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $404.40M 10-Q · filed 2025-08-11 | $368.94M derived: sum of 3 quarters · filed 2026-03-02 | $365.74M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-03-31 | $228.30M 10-Q · filed 2025-05-12 | $228.30M 10-Q · filed 2024-05-10 | $192.83M derived: sum of 2 quarters · filed 2026-03-02 | $189.63M derived: sum of 3 quarters · filed 2026-03-02 | $427.75M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2023-12-31 | -$35.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$38.67M derived: sum of 2 quarters · filed 2026-03-02 | $199.46M derived: sum of 3 quarters · filed 2026-03-02 | $195.63M 10-K · filed 2026-03-02 | |||
| 2023-09-30 | -$3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $234.92M derived: sum of 2 quarters · filed 2024-11-12 | $231.10M 10-Q · filed 2024-11-12 | $334.69M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-06-30 | $238.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $234.30M 10-Q · filed 2024-08-09 | $337.89M derived: sum of 3 quarters · filed 2025-03-03 | $334.57M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-03-31 | -$3.82M 10-Q · filed 2024-05-10 | $99.76M derived: sum of 2 quarters · filed 2025-03-03 | $96.45M derived: sum of 3 quarters · filed 2025-03-03 | $93.14M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2022-12-31 | $103.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $100.27M derived: sum of 2 quarters · filed 2025-03-03 | $96.96M derived: sum of 3 quarters · filed 2025-03-03 | $93.65M 10-K · filed 2025-03-03 | |||
| 2022-09-30 | -$3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$6.63M derived: sum of 2 quarters · filed 2023-11-09 | -$9.94M 10-Q · filed 2023-11-09 | -$13.74M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | -$3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$6.63M 10-Q · filed 2023-08-09 | -$10.43M derived: sum of 3 quarters · filed 2024-02-29 | -$1.76M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | -$3.31M 10-Q · filed 2023-05-10 | -$7.12M derived: sum of 2 quarters · filed 2024-02-29 | $1.55M derived: sum of 3 quarters · filed 2024-02-29 | $113.01M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | -$3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $4.86M derived: sum of 2 quarters · filed 2024-02-29 | $116.32M derived: sum of 3 quarters · filed 2024-02-29 | $104.67M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $8.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $120.13M derived: sum of 2 quarters · filed 2022-11-09 | $108.48M 10-Q · filed 2022-11-09 | $96.41M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $111.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $99.81M 10-Q · filed 2022-08-09 | $87.75M derived: sum of 3 quarters · filed 2023-03-01 | $73.69M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | -$11.65M 10-Q · filed 2022-05-10 | -$23.72M derived: sum of 2 quarters · filed 2023-03-01 | -$37.77M derived: sum of 3 quarters · filed 2023-03-01 | -$125.47M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | -$12.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$26.12M derived: sum of 2 quarters · filed 2023-03-01 | -$113.82M derived: sum of 3 quarters · filed 2023-03-01 | -$45.56M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | -$14.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$101.76M derived: sum of 2 quarters · filed 2021-11-09 | -$33.49M 10-Q · filed 2021-11-09 | -$32.49M 10-Q · filed 2020-11-09 | -$47.25M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | -$87.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$19.44M 10-Q · filed 2021-08-09 | -$33.19M derived: sum of 3 quarters · filed 2022-03-01 | -$46.92M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $68.26M 10-Q · filed 2021-05-10 | $54.51M derived: sum of 2 quarters · filed 2022-03-01 | $40.78M derived: sum of 3 quarters · filed 2022-03-01 | $84.87M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$13.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$27.48M derived: sum of 2 quarters · filed 2022-03-01 | $16.61M derived: sum of 3 quarters · filed 2022-03-01 | $24.95M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | -$13.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $30.36M derived: sum of 2 quarters · filed 2020-11-09 | $38.70M 10-Q · filed 2020-11-09 | $58.12M derived: sum of 4 quarters · filed 2021-03-16 | |||
| 2019-06-30 | $44.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $52.43M 10-Q · filed 2020-08-10 | $71.85M derived: sum of 3 quarters · filed 2021-03-16 | $62.41M derived: sum of 4 quarters · filed 2021-03-16 | |||
| 2019-03-31 | $8.34M 10-Q · filed 2020-05-11 | $27.76M derived: sum of 2 quarters · filed 2021-03-16 | $18.32M derived: sum of 3 quarters · filed 2021-03-16 | $8.24M derived: sum of 4 quarters · filed 2021-03-16 | |||
| 2018-12-31 | $19.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $9.98M derived: sum of 2 quarters · filed 2021-03-16 | -$104.00K derived: sum of 3 quarters · filed 2021-03-16 | -$10.87M 10-K · filed 2021-03-16 | |||
| 2018-09-30 | -$9.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$19.52M derived: sum of 2 quarters · filed 2019-11-12 | -$30.29M 10-Q · filed 2019-11-12 | -$40.56M derived: sum of 4 quarters · filed 2020-03-16 | |||
| 2018-06-30 | -$10.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$20.85M 10-Q · filed 2019-08-09 | -$31.12M derived: sum of 3 quarters · filed 2020-03-16 | -$40.95M derived: sum of 4 quarters · filed 2020-03-16 | |||
| 2018-03-31 | -$10.77M 10-Q · filed 2019-05-10 | -$21.04M derived: sum of 2 quarters · filed 2020-03-16 | -$30.87M derived: sum of 3 quarters · filed 2020-03-16 | -$33.74M derived: sum of 4 quarters · filed 2020-03-16 | |||
| 2017-12-31 | -$10.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$20.10M derived: sum of 2 quarters · filed 2020-03-16 | -$22.97M derived: sum of 3 quarters · filed 2020-03-16 | -$32.25M 10-K · filed 2020-03-16 | |||
| 2017-09-30 | -$9.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$12.70M derived: sum of 2 quarters · filed 2018-11-09 | -$21.97M 10-Q · filed 2018-11-09 | -$32.11M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2017-06-30 | -$2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$12.14M 10-Q · filed 2018-08-09 | -$22.28M derived: sum of 3 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | -$9.28M 10-Q · filed 2018-05-10 | -$19.41M derived: sum of 2 quarters · filed 2019-03-18 | |||||
| 2016-12-31 | -$10.13M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$5.91M 10-K · filed 2019-03-18 | |||||
| 2016-09-30 | $4.22M 10-Q · filed 2017-11-09 | ||||||
| 2015-12-31 | $29.94M 10-K · filed 2018-03-19 | ||||||
| 2014-03-31 | $14.95M 10-Q · filed 2014-05-12 | $9.25M derived: sum of 2 quarters · filed 2014-05-12 | $9.38M derived: sum of 3 quarters · filed 2014-05-12 | $8.05M derived: sum of 4 quarters · filed 2014-05-12 | |||
| 2013-12-31 | -$5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$5.56M derived: sum of 2 quarters · filed 2014-03-17 | -$6.89M derived: sum of 3 quarters · filed 2014-03-17 | -$7.62M 10-K · filed 2014-03-17 | |||
| 2013-09-30 | $131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$1.20M derived: sum of 2 quarters · filed 2013-11-13 | -$1.93M 10-Q · filed 2013-11-13 | $21.73M derived: sum of 4 quarters · filed 2014-05-12 | |||
| 2013-06-30 | -$1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$2.06M 10-Q · filed 2013-08-09 | $21.60M derived: sum of 3 quarters · filed 2014-05-12 | $17.19M derived: sum of 4 quarters · filed 2014-05-12 | |||
| 2013-03-31 | -$728.00K 10-Q · filed 2014-05-12 | $22.93M derived: sum of 2 quarters · filed 2014-05-12 | $18.52M derived: sum of 3 quarters · filed 2014-05-12 | $12.20M derived: sum of 4 quarters · filed 2014-05-12 | |||
| 2012-12-31 | $23.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $19.25M derived: sum of 2 quarters · filed 2014-03-17 | $12.93M derived: sum of 3 quarters · filed 2014-03-17 | $9.62M 10-K · filed 2014-03-17 | |||
| 2012-09-30 | -$4.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$10.73M derived: sum of 2 quarters · filed 2013-11-13 | -$14.03M 10-Q · filed 2013-11-13 | $5.96M derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2012-06-30 | -$6.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$9.63M 10-Q · filed 2013-08-09 | $10.36M derived: sum of 3 quarters · filed 2014-03-17 | $10.47M derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2012-03-31 | -$3.31M 10-Q · filed 2013-05-10 | $16.68M derived: sum of 2 quarters · filed 2014-03-17 | $16.80M derived: sum of 3 quarters · filed 2014-03-17 | $20.98M derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2011-12-31 | $19.99M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $20.10M derived: sum of 2 quarters · filed 2014-03-17 | $24.29M derived: sum of 3 quarters · filed 2014-03-17 | $31.93M 10-K · filed 2014-03-17 | |||
| 2011-09-30 | $110.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-09 | $4.30M derived: sum of 2 quarters · filed 2012-11-09 | $11.94M 10-Q · filed 2012-11-09 | -$35.56M derived: sum of 4 quarters · filed 2013-11-13 | |||
| 2011-06-30 | $4.19M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30 | $11.83M 10-Q/A · filed 2012-08-30 | -$35.67M derived: sum of 3 quarters · filed 2013-11-13 | -$42.34M derived: sum of 4 quarters · filed 2013-11-13 | |||
| 2011-03-31 | $7.65M 10-Q · filed 2012-05-10 | -$39.85M derived: sum of 2 quarters · filed 2013-11-13 | -$46.53M derived: sum of 3 quarters · filed 2013-11-13 | ||||
| 2010-12-31 | -$47.50M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-13 | -$54.17M derived: sum of 2 quarters · filed 2013-11-13 | -$15.66M 10-K/A · filed 2013-11-13 | $25.04M 10-K · filed 2012-03-13 | |||
| 2010-09-30 | -$6.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $31.84M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $38.51M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | -$30.24M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |